首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Expression of DNA-dependent protein kinase catalytic subunit in laryngeal squamous cell carcinoma and its importance
【2h】

Expression of DNA-dependent protein kinase catalytic subunit in laryngeal squamous cell carcinoma and its importance

机译:DNA依赖性蛋白激酶催化亚基在喉鳞状细胞癌中的表达及其意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to explore the expression and distribution of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) in tumor tissues and adjacent normal mucosa tissues of patients with laryngeal squamous cell carcinoma (LSCC), and further analyze the association between the expression and the clinicopathological parameters of patients with LSCC. Clinical data of tumor tissues and corresponding adjacent normal mucosa tissues of pathologically diagnosed LSCC in 96 cases were collected in the present study. Of these specimens, the mRNA and protein expression levels of DNA-PKcs in LSCC tissues and the adjacent normal mucosa tissues were analyzed via reverse transcription-quantitative polymerase chain reaction and western blot analysis. Immunohistochemistry was used to detect expression and distribution of DNA-PKcs protein in LSCC tissues and corresponding adjacent normal mucosa tissues. The association between DNA-PKcs expression and the specific clinicopathologic features was evaluated by the χ2 test. Kaplan-Meier and Cox proportional hazards regression models were used to analyze the data. It was revealed that the expression of DNA-PKcs mRNA and protein was significantly higher in LSCC tissues than the adjacent normal mucosa tissues (P<0.05). DNA-PKcs was expressed predominantly in the nucleus. DNA-PKcs expression showed significant correlation with the differentiation degree of LSCC (P<0.05), and changes of DNA-PKcs expression gradually increased with the decrease of the differentiation degree. However, DNA-PKcs expression was not significantly associated with sex, age, lymph node metastasis or TMN stage (P>0.05). Patients with LSCC exhibited higher DNA-PKcs expression had markedly shorter survival than those with lower DNA-PKcs expression. In conclusion, the present results suggested that the expression levels of DNA-PKcs were significantly increased in LSCC tumor tissues than in adjacent normal mucosa. DNA-PKcs expression was correlated with differentiation of LSCC, and may become a novel prognostic marker for patients with LSCC.
机译:本研究的目的是探讨DNA依赖性蛋白激酶催化亚基(DNA-PKcs)在喉鳞状细胞癌(LSCC)患者的肿瘤组织和邻近正常黏膜组织中的表达和分布,并进一步分析其相关性。 LSCC患者的表达与临床病理参数之间的关系本研究收集了96例经病理诊断为LSCC的肿瘤组织及相应的邻近正常黏膜组织的临床资料。在这些标本中,通过逆转录-定量聚合酶链反应和蛋白质印迹分析来分析LSCC组织和邻近正常粘膜组织中DNA-PKcs的mRNA和蛋白表达水平。免疫组织化学法检测DNA-PKcs蛋白在LSCC组织及相应的正常黏膜组织中的表达和分布。通过χ 2 检验评估DNA-PKcs表达与特定临床病理特征之间的关系。 Kaplan-Meier和Cox比例风险回归模型用于分析数据。结果表明,LSCC组织中DNA-PKcs mRNA和蛋白的表达明显高于邻近的正常黏膜组织(P <0.05)。 DNA-PKcs主要在细胞核中表达。 DNA-PKcs的表达与LSCC的分化程度呈显着相关(P <0.05),DNA-PKcs的表达随着分化程度的降低而逐渐增加。然而,DNA-PKcs的表达与性别,年龄,淋巴结转移或TMN分期无关(P> 0.05)。 LSCC患者表现出较高的DNA-PKcs表达,其生存期明显短于DNA-PKcs表达较低的患者。总之,目前的结果表明,LSCC肿瘤组织中DNA-PKcs的表达水平显着高于邻近的正常粘膜。 DNA-PKcs的表达与LSCC的分化有关,可能成为LSCC患者的一种新的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号